EPAM Q4 revenue rises 7.9% to $1.248 billion; 2025 EPS guidance sits below 2024 results
EPAM reported fourth-quarter 2024 revenue of $1.248 billion, up 7.9% year over year, and GAAP diluted EPS of $1.80, up 8.4%. For full-year 2025, it guided to non-GAAP diluted EPS of $10.45 to $10.75 and GAAP diluted EPS of $6.78 to $7.08, compared with 2024 actuals of $10.86 non-GAAP and $7.84 GAAP.
Key points
- Q4 2024 revenue $1.248 billion, up 7.9%; organic constant currency growth 1.0%
- Full-year 2024 revenue $4.728 billion, up 0.8%; 2024 GAAP diluted EPS $7.84, including a $68.8 million Poland R&D incentive benefit
- 2025 full-year guidance: revenue growth of 10.0% to 14.0%, with non-GAAP diluted EPS of $10.45 to $10.75
- First-quarter 2025 guidance: revenue of $1.275 billion to $1.290 billion and non-GAAP diluted EPS of $2.22 to $2.32
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:17 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 19, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.